Lunate Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-450,000
Closed -$806K 12
2026
Q1
$806K Hold
450,000
0.67% 6
2025
Q4
$423K Hold
450,000
0.16% 6
2025
Q3
$135K Hold
450,000
0.06% 6
2025
Q2
$118K Buy
+450,000
New +$66.7K 0.07% 6

Other funds holding RVMDW

Lunate Capital's RVMDW Position: Q2 2026 in Review

Lunate Capital sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2026, closing a stake of 450,000 shares — an estimated $806K sold.

Lunate Capital first reported a position in RVMDW in Q2 2025 and held it in 4 quarters. The position peaked at $806K in Q1 2026. 2 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Lunate Capital reported no remaining Revolution Medicines Inc Warrant position as of Q2 2026 after selling out during the quarter.
  • Lunate Capital sold 450,000 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $806K.
  • Lunate Capital first reported a position in Revolution Medicines Inc Warrant in Q2 2025 and held it in 4 quarters.
  • Lunate Capital's Revolution Medicines Inc Warrant position peaked at $806K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Lunate Capital's 13F filing for Q2 2026, filed 23 Jul 2026.